Renergen Ltd. (REN) - Net Assets
Based on the latest financial reports, Renergen Ltd. (REN) has net assets worth ZAC974.90 Million ZAC (≈ $518.11K USD) as of August 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ZAC2.68 Billion ≈ $1.42 Million USD) and total liabilities (ZAC1.70 Billion ≈ $904.24K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Renergen Ltd. (REN) asset resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ZAC974.90 Million |
| % of Total Assets | 36.43% |
| Annual Growth Rate | N/A |
| 5-Year Change | 440.0% |
| 10-Year Change | 1126.13% |
| Growth Volatility | 71.01 |
Renergen Ltd. - Net Assets Trend (2013–2025)
This chart illustrates how Renergen Ltd.'s net assets have evolved over time, based on quarterly financial data. Also explore Renergen Ltd. total assets for the complete picture of this company's asset base.
Annual Net Assets for Renergen Ltd. (2013–2025)
The table below shows the annual net assets of Renergen Ltd. from 2013 to 2025. For live valuation and market cap data, see REN company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-02-28 | ZAC1.11 Billion ≈ $592.36K |
-15.63% |
| 2024-02-29 | ZAC1.32 Billion ≈ $702.10K |
+57.24% |
| 2023-02-28 | ZAC840.20 Million ≈ $446.53K |
+193.46% |
| 2022-02-28 | ZAC286.31 Million ≈ $152.16K |
+38.71% |
| 2021-02-28 | ZAC206.41 Million ≈ $109.70K |
-16.51% |
| 2020-02-29 | ZAC247.23 Million ≈ $131.39K |
+50.54% |
| 2019-02-28 | ZAC164.23 Million ≈ $87.28K |
+139.19% |
| 2018-02-28 | ZAC68.66 Million ≈ $36.49K |
-22.99% |
| 2017-02-28 | ZAC89.16 Million ≈ $47.38K |
-1.92% |
| 2016-02-29 | ZAC90.91 Million ≈ $48.31K |
+760.84% |
| 2015-02-28 | ZAC-13.76 Million ≈ $-7.31K |
-28.82% |
| 2014-02-28 | ZAC-10.68 Million ≈ $-5.67K |
-133.99% |
| 2013-02-28 | ZAC-4.56 Million ≈ $-2.43K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Renergen Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 19437037400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (February 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ZAC1.21 Billion | 116.53% |
| Other Comprehensive Income | ZAC26.32 Million | 2.53% |
| Other Components | ZAC946.00K | 0.09% |
| Total Equity | ZAC1.04 Billion | 100.00% |
Renergen Ltd. Competitors by Market Cap
The table below lists competitors of Renergen Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kuantum Papers Limited
NSE:KUANTUM
|
$75.88 Million |
|
Western Energy Services Corp.
TO:WRG
|
$75.89 Million |
|
RoyalTek Co Ltd
TWO:3306
|
$75.89 Million |
|
Groupe Minoteries SA
SW:GMI
|
$75.90 Million |
|
Snowman Logistics Limited
NSE:SNOWMAN
|
$75.84 Million |
|
ArcelorMittal South Africa Limited
JSE:ACL
|
$75.82 Million |
|
Sypris Solutions Inc
NASDAQ:SYPR
|
$75.77 Million |
|
Pelthos Therapeutics Inc.
NYSE MKT:PTHS
|
$75.77 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Renergen Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,243,647,000 to 1,038,632,000, a change of -205,015,000 (-16.5%).
- Net loss of 236,120,000 reduced equity.
- New share issuances of 39,316,000 increased equity.
- Other comprehensive income decreased equity by 755,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ZAC-236.12 Million | -22.73% |
| Share Issuances | ZAC39.32 Million | +3.79% |
| Other Comprehensive Income | ZAC-755.00K | -0.07% |
| Other Changes | ZAC-7.46 Million | -0.72% |
| Total Change | ZAC- | -16.48% |
Book Value vs Market Value Analysis
This analysis compares Renergen Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 131.46x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-02-28 | ZAC-0.62 | ZAC920.00 | x |
| 2014-02-28 | ZAC-1.45 | ZAC920.00 | x |
| 2016-02-29 | ZAC1.82 | ZAC920.00 | x |
| 2017-02-28 | ZAC1.22 | ZAC920.00 | x |
| 2018-02-28 | ZAC1.01 | ZAC920.00 | x |
| 2019-02-28 | ZAC2.08 | ZAC920.00 | x |
| 2020-02-29 | ZAC2.25 | ZAC920.00 | x |
| 2021-02-28 | ZAC1.76 | ZAC920.00 | x |
| 2022-02-28 | ZAC2.35 | ZAC920.00 | x |
| 2023-02-28 | ZAC6.25 | ZAC920.00 | x |
| 2024-02-29 | ZAC8.47 | ZAC920.00 | x |
| 2025-02-28 | ZAC7.00 | ZAC920.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Renergen Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -22.73%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -453.09%
- • Asset Turnover: 0.02x
- • Equity Multiplier: 2.26x
- Recent ROE (-22.73%) is below the historical average (-15.16%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | ZAC24.00 Million |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | ZAC-5.00 Million |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | ZAC-4.78 Million |
| 2016 | -16.00% | 0.00% | 0.00x | 1.22x | ZAC-25.70 Million |
| 2017 | -17.50% | -1000.06% | 0.01x | 1.27x | ZAC-27.06 Million |
| 2018 | -50.16% | -1407.31% | 0.03x | 1.41x | ZAC-48.70 Million |
| 2019 | -24.90% | -1505.72% | 0.01x | 1.25x | ZAC-63.04 Million |
| 2020 | -21.28% | -1996.93% | 0.00x | 2.53x | ZAC-77.34 Million |
| 2021 | -20.65% | -2214.03% | 0.00x | 3.78x | ZAC-63.26 Million |
| 2022 | -11.79% | -1279.86% | 0.00x | 4.07x | ZAC-62.38 Million |
| 2023 | -3.18% | -210.65% | 0.01x | 2.26x | ZAC-110.75 Million |
| 2024 | -8.87% | -380.88% | 0.01x | 2.18x | ZAC-234.64 Million |
| 2025 | -22.73% | -453.09% | 0.02x | 2.26x | ZAC-339.98 Million |
Industry Comparison
This section compares Renergen Ltd.'s net assets metrics with peer companies in the Oil & Gas E&P industry.
No peer company data available for comparison.
About Renergen Ltd.
Renergen Limited, an investment holding company, engages in the alternative and renewable energy businesses in South Africa and sub-Saharan Africa. It operates through Tetra4 and Cryovation segments. The company explores for, develops, and sells liquefied natural gas and helium gas. It also develops Cryo-Vacc technology, which enables the transportation of vaccines and biologics at low temperatur… Read more